Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures Graciana L. GalianaAngela C. GauthierRichard H. Mattson Review Article Open access 24 July 2017 Pages: 329 - 339
Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region Renée DagenaisKyle John WilbyMary H. H. Ensom Systematic Review Open access 26 July 2017 Pages: 341 - 361
Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist Kaoru ToyamaHidetoshi FuruieHitoshi Ishizuka Original Research Article Open access 17 May 2017 Pages: 363 - 370
Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada Ryosuke KuribayashiScott Appleton Original Research Article Open access 02 June 2017 Pages: 371 - 379
A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma Takuya ShoMitsuru NakanishiNaoya Sakamoto Original Research Article Open access 01 June 2017 Pages: 381 - 388
A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation Satoru OkaYoko ObataTomoya Nishino Original Research Article Open access 25 May 2017 Pages: 389 - 396
A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis Koichiro HommaJoe YoshizawaYasuhiko Homma Original Research Article Open access 02 June 2017 Pages: 397 - 402
Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus Yayoi NishidaYasuo TakahashiSatoshi Asai Original Research Article Open access 03 June 2017 Pages: 403 - 412
Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction Kenji EgusaFumiaki OkazakiMarkus Wolkenhauer Original Research Article Open access 13 September 2017 Pages: 413 - 418
Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study Jordi GuitartMaría Isabel VargasAlmudena Sanz Original Research Article Open access 25 July 2017 Pages: 419 - 425
A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m2 (Dralitem® vs. Temodal® Capsules) in Patients with Primary Tumors of the Central Nervous System Under Fasting Conditions Alejandro MuggeriMiguel VagoSantiago Pérez-Lloret Original Research Article Open access 29 July 2017 Pages: 427 - 434
Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine Tramaine YoungMatt DanielJane Green Original Research Article Open access 16 August 2017 Pages: 435 - 440
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial David J. WebbBlai CollDick de Zeeuw Original Research Article Open access 22 August 2017 Pages: 441 - 448
Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine Heather SkorEvan B. SmithHaig Bozigian Original Research Article Open access 03 August 2017 Pages: 449 - 459
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? Paolo GrassiElena VerzoniGiuseppe Procopio Original Research Article Open access 11 August 2017 Pages: 461 - 467
Pharmacokinetics of Bevacizumab in Three Patients Under the Age of 3 Years with CNS Malignancies Johannes GojoRobert SauermannAndreas Peyrl short communication Open access 02 June 2017 Pages: 469 - 474
Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant Kazuhiko Hanada Short Communication Open access 23 June 2017 Pages: 475 - 480
Effectiveness and Safety of Switching from Innovator Infliximab to Biosimilar CT-P13 in Inflammatory Rheumatic Diseases: A Real-World Case Study Cristina Vergara-DangondMarina Sáez BellóJuan José Alegre-Sancho Short Communication Open access 30 June 2017 Pages: 481 - 485
Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode” Karen Rascati Letter to the Editor Open access 20 May 2017 Pages: 487 - 488